WO1999054954A3 - Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections - Google Patents
Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections Download PDFInfo
- Publication number
- WO1999054954A3 WO1999054954A3 PCT/DE1999/001177 DE9901177W WO9954954A3 WO 1999054954 A3 WO1999054954 A3 WO 1999054954A3 DE 9901177 W DE9901177 W DE 9901177W WO 9954954 A3 WO9954954 A3 WO 9954954A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hiv
- pharmaceuticals
- radio
- radioimmunological
- eliminated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU44971/99A AU4497199A (en) | 1998-04-15 | 1999-04-15 | Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
JP2000545211A JP2002512261A (en) | 1998-04-15 | 1999-04-15 | CD4 radioimmune drug for treating HIV infection |
EP99927685A EP1071475A2 (en) | 1998-04-15 | 1999-04-15 | Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
DE19980721T DE19980721D2 (en) | 1998-04-15 | 1999-04-15 | CD4 radioimmunopharmaceuticals used to treat HIV infection |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19826307.4 | 1998-04-15 | ||
DE1998126307 DE19826307A1 (en) | 1998-03-08 | 1998-04-15 | CD4 radio immunological pharmaceuticals |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999054954A2 WO1999054954A2 (en) | 1999-10-28 |
WO1999054954A3 true WO1999054954A3 (en) | 2000-01-20 |
Family
ID=7870747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1999/001177 WO1999054954A2 (en) | 1998-04-15 | 1999-04-15 | Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1071475A2 (en) |
JP (1) | JP2002512261A (en) |
AU (1) | AU4497199A (en) |
DE (1) | DE19980721D2 (en) |
WO (1) | WO1999054954A2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991004050A1 (en) * | 1989-09-14 | 1991-04-04 | Board Of Regents, The University Of Texas System | Therapeutic compositions; methods for treatment of hiv infections |
WO1991011461A1 (en) * | 1990-01-26 | 1991-08-08 | Biogen, Inc. | C4 binding protein fusion proteins |
WO1994004191A1 (en) * | 1992-08-13 | 1994-03-03 | Antisoma Limited | Medical treatment |
WO1997003198A2 (en) * | 1995-07-07 | 1997-01-30 | Texas A & M University System | Nucleotide and amino acid sequence and uses thereof |
WO1999045969A2 (en) * | 1998-03-08 | 1999-09-16 | Wolfgang Bergter | Radioimmuno-pharmacon for treating the hiv-1 infection |
-
1999
- 1999-04-15 WO PCT/DE1999/001177 patent/WO1999054954A2/en not_active Application Discontinuation
- 1999-04-15 EP EP99927685A patent/EP1071475A2/en not_active Withdrawn
- 1999-04-15 JP JP2000545211A patent/JP2002512261A/en active Pending
- 1999-04-15 DE DE19980721T patent/DE19980721D2/en not_active Ceased
- 1999-04-15 AU AU44971/99A patent/AU4497199A/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991004050A1 (en) * | 1989-09-14 | 1991-04-04 | Board Of Regents, The University Of Texas System | Therapeutic compositions; methods for treatment of hiv infections |
WO1991011461A1 (en) * | 1990-01-26 | 1991-08-08 | Biogen, Inc. | C4 binding protein fusion proteins |
WO1994004191A1 (en) * | 1992-08-13 | 1994-03-03 | Antisoma Limited | Medical treatment |
WO1997003198A2 (en) * | 1995-07-07 | 1997-01-30 | Texas A & M University System | Nucleotide and amino acid sequence and uses thereof |
WO1999045969A2 (en) * | 1998-03-08 | 1999-09-16 | Wolfgang Bergter | Radioimmuno-pharmacon for treating the hiv-1 infection |
Also Published As
Publication number | Publication date |
---|---|
JP2002512261A (en) | 2002-04-23 |
AU4497199A (en) | 1999-11-08 |
WO1999054954A2 (en) | 1999-10-28 |
EP1071475A2 (en) | 2001-01-31 |
DE19980721D2 (en) | 2001-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119369T1 (en) | MEDICAL PREPARATIONS FOR THE THERAPEUTIC TREATMENT OF ALPHA-MILK DISEASE | |
HUP0104717A2 (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
NZ601544A (en) | Combination therapy for the treatment of ocular neovascular disorders | |
TW265265B (en) | ||
DK0751781T3 (en) | Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic diseases | |
NO20015584L (en) | Long-lasting insulin-tropic peptides and conjugates and use in the manufacture of medicaments for treatment | |
Sillanpää | Clonidine prophylaxis of childhood migraine and other vascular headache: a double blind study of 57 children | |
EP0330227A3 (en) | Derivatives of soluble t-4 | |
DE60128912D1 (en) | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika | |
BR9808100A (en) | Use of amandantine to treat hepatitis c. | |
CA2315277A1 (en) | Pharmaceutical compositions containing the long pentraxin ptx3 | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
DE69733089D1 (en) | Treatment of osteotarthritis by administration of poly-N-acetyl-D-glucosamine | |
NO943288L (en) | Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease | |
JPS55151566A (en) | 66substitutedd111alkyleneemorphanthridine* its manufacture and medicine containing it | |
WO1999054954A3 (en) | Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections | |
ZA202304877B (en) | Recombinant adeno-associated viruses with enhanced liver tropism and uses thereof | |
YU56702A (en) | Use of fsh for treating infertility | |
TR199901958T2 (en) | A medicine against infertility and to increase fertility. | |
ATE554793T1 (en) | CONJUGATE | |
BR0212928A (en) | Process for treating hapatitis c viral infection in non-responders | |
EA199800770A1 (en) | DRUGS FOR THERAPEUTIC TREATMENT OF VIRAL HEPATITIS | |
TR200000728T2 (en) | The use of IFN-alpha and amantadine in the treatment of chronic hepatitis C. | |
JP2004513150A5 (en) | ||
DK0788355T3 (en) | Use of intravenously administered iron for the treatment of tumor diseases and / or infectious diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09673557 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999927685 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999927685 Country of ref document: EP |
|
REF | Corresponds to |
Ref document number: 19980721 Country of ref document: DE Date of ref document: 20010329 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 19980721 Country of ref document: DE |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999927685 Country of ref document: EP |